ARTICLE | Distillery Therapeutics
RECK, an inhibitor of amyloid precursor protein cleavage, as a target for Alzheimer’s
April 7, 2021 5:03 PM UTC
DISEASE CATEGORY: Neurology
INDICATION: Alzheimer’s disease...
DISEASE CATEGORY: Neurology
INDICATION: Alzheimer’s disease...